This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Venditti, M Articles by Martino, P Search for Related Content PubMed PubMed Citation Articles by Venditti, M Articles by Martino, P

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1989 April; 33(4): 580-582

Antimicrobial susceptibilities of Streptococcus species that cause septicemia in neutropenic patients.

Cattedra di Patologia Medica III, Università La Sapienza, Rome, Italy.

ABSTRACT

Sixty-three consecutive streptococcal blood isolates from neutropenic patients, represented mainly by viridans group streptococci, were evaluated in vitro for antibiotic susceptibility. Of these isolates, 79.3% were highly susceptible to penicillin (MIC, less than or equal to 0.12 microgram/ml). Overall, imipenem was the most active agent, followed by teicoplanin and vancomycin. All other agents showed decreased activity against streptococcal isolates that were not highly susceptible to penicillin.

This article has been cited by other articles:

• Balsalobre, L., Ferrandiz, M. J., Linares, J., Tubau, F., de la Campa, A. G. (2003). Viridans Group Streptococci Are Donors in Horizontal Transfer of Topoisomerase IV Genes to Streptococcus pneumoniae. Antimicrob. Agents Chemother. 47: 2072-2081 [Abstract] [Full Text]  
• de la Campa, A. G., Ferrandiz, M.-J., Tubau, F., Pallares, R., Manresa, F., Linares, J. (2003). Genetic Characterization of Fluoroquinolone-Resistant Streptococcus pneumoniae Strains Isolated during Ciprofloxacin Therapy from a Patient with Bronchiectasis. Antimicrob. Agents Chemother. 47: 1419-1422 [Abstract] [Full Text]  
• Gershon, A. S., de Azavedo, J. C. S., McGeer, A., Ostrowska, K. I., Church, D., Hoban, D. J., Harding, G. K. M., Weiss, K., Abbott, L., Smaill, F., Gourdeau, M., Murray, G., Low, D. E. (2002). Activities of New Fluoroquinolones, Ketolides, and Other Antimicrobials against Blood Culture Isolates of Viridans Group Streptococci from across Canada, 2000. Antimicrob. Agents Chemother. 46: 1553-1556 [Abstract] [Full Text]  
• Ferrándiz, M. J., Fenoll, A., Liñares, J., De La Campa, A. G. (2000). Horizontal Transfer of parC and gyrA in Fluoroquinolone-Resistant Clinical Isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 44: 840-847 [Abstract] [Full Text]  
• Ferrándiz, M. J., Oteo, J., Aracil, B., Gómez-Garcés, J. L., De La Campa, A. G. (1999). Drug Efflux and parC Mutations Are Involved in Fluoroquinolone Resistance in Viridans Group Streptococci. Antimicrob. Agents Chemother. 43: 2520-2523 [Abstract] [Full Text]  
• Wisplinghoff, H., Reinert, R. R., Cornely, O., Seifert, H. (1999). Molecular Relationships and Antimicrobial Susceptibilities of Viridans Group Streptococci Isolated from Blood of Neutropenic Cancer Patients. J. Clin. Microbiol. 37: 1876-1880 [Abstract] [Full Text]  
• Rosser, S. J., Alfa, M. J., Hoban, S., Kennedy, J., Harding, G. K. (1999). E Test versus Agar Dilution for Antimicrobial Susceptibility Testing of Viridans Group Streptococci. J. Clin. Microbiol. 37: 26-30 [Abstract] [Full Text]  
• González, I., Georgiou, M., Alcaide, F., Balas, D., Liñares, J., de la Campa, A. G. (1998). Fluoroquinolone Resistance Mutations in the parC, parE, and gyrA Genes of Clinical Isolates of Viridans Group Streptococci. Antimicrob. Agents Chemother. 42: 2792-2798 [Abstract] [Full Text]